RNS Number:3327E
Newton Management Ltd
27 November 2002
Date of Disclosure 27TH NOVEMBER 2002.
DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3
OF THE CITY CODE ON TAKEOVERS AND MERGERS
Date of dealing 26TH NOVEMBER 2002.
Dealing in POWDERJECT PHARMACEUTICALS (name of company)
1) Class of securities (eg ordinary shares) ORDINARY USD 0 50
2) Amount bought Amount sold Price per unit
30000 3.23
3) Resultant total of the same class owned or controlled
(and percentage of class) 3,192,854 (3.50%) AND TAKE OFF.
4) Party making disclosure NEWTON MANAGEMENT LIMITED & ITS SUBSIDIARIES
5) EITHER (a) Name of purchaser/vendor (Note 1)
OR (b) if dealing for discretionary client(s), name of fund
management organisation NEWTON MANAGEMENT LIMITED & ITS
SUBSIDIARIES
6) Reason for disclosure (Note 2)
(a) associate of (i) offeror (Note 3) NO
(ii) offeree company NO
Specify which category or categories of associate (1-8 overleaf)
If category (8), explain
(b) Rule 8.3 (ie disclosure because of ownership or control of 1%
or more of the class of relevant securities dealt in) YES
Signed, for and on behalf of the party named in (4) above N/A
(Also print name of signatory) LEE WRIGHT
Telephone and extension number 020 7653 2205
Note 1. Specify owner, not nominee or vehicle company. If relevant, also
identify controller of owner, eg where an owner normally acts on
instructions of a controller
Note 2. Disclosure might be made for more than one reason; if so, state all
reasons.
Note 3. Specify which offeror if there is more than one.
Note 4. When an arrangement exists with any offeror, with the offeree company
or which an associate of any offeror or of the offeree company
in relation to relevant securities, details of such arrangement must
be disclosed, as required by Note 6 on Rule 8
Note 5. It may be necessary, particularly when disclosing derivative
transactions, to append a sheet to this disclosure form so that
relevant information can be given.
Note 6. In the case of an average price bargain, each underlying trade
should be disclosed.
For full details of disclosure requirements, see Rule 8 of the Code. If in
doubt, contact the Panel on Takeovers and Mergers, Tel No: 020 7382 9026
This information is provided by RNS
The company news service from the London Stock Exchange
END
DCCIIFFALVLDFIF
|